IMPACT
STUDY BASICS
Have you been diagnosed with a substance use disorder? Are you pregnant? You may be eligible for a research study to learn about MyPath, a web-based, reproductive planning decision support tool, and its effect on women's birth control decisions. Compensation is provided.
STUDY PURPOSE
The purpose of this study is to compare the effect of a web-based, patient-centered, reproductive planning decision support tool, called MyPath, on postpartum contraceptive decision-making among women with substance use disorders.
COULD THIS STUDY BE RIGHT FOR YOU?
- 18+ years old
- Diagnosed with substance use disorder
- Pregnant and planning to deliver at Magee-Women's Hospital
OR
- Recently delivered at Magee-Women's Hospital
WHAT PARTICIPANTS CAN EXPECT
You will be randomized (flip of a coin) to receive either MyPath or usual care.
- The MyPath arm: You will use the tool on a computerized tablet.
- The usual care arm: You be asked to review a packet of written materials focused on postpartum health topics
Once you are placed in a study group; you will be asked to complete a series of questionnaires until 18-months after your delivery.
IRB: STUDY20110324
- sIRB Implementation of a patient-centered, reproductive planning decision support tool (MyPath) among women with substance use disorder in the immediate postpartum periodMEET THE RESEARCHER

Elizabeth Krans
Elizabeth Krans, MD, MSc, is Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh. A graduate of the University of Mississippi, Dr. Krans’ research interests include improving health care delivery to pregnant women with opioid use disorder and improving the risk assessment process in prenatal care to improve the efficiency and effectiveness of prenatal care delivery for women with multiple psychosocial risk factors.